Belpointe Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $993K | Sell |
11,461
-5,251
| -31% | -$503K | 0.04% | 455 |
|
|
2025
Q4 | $1.61M | Buy |
16,712
+6,088
| +57% | +$591K | 0.06% | 277 |
|
|
2025
Q3 | $1.01M | Buy |
10,624
+3,099
| +41% | +$285K | 0.04% | 399 |
|
|
2025
Q2 | $656K | Buy |
7,525
+32
| +0.4% | +$2.71K | 0.03% | 485 |
|
|
2025
Q1 | $673K | Sell |
7,493
-607
| -7% | -$54.3K | 0.04% | 460 |
|
|
2024
Q4 | $718K | Buy |
8,100
+60
| +0.7% | +$5.19K | 0.04% | 419 |
|
|
2024
Q3 | $724K | Buy |
8,040
+1,284
| +19% | +$108K | 0.04% | 403 |
|
|
2024
Q2 | $532K | Sell |
6,756
-10,809
| -62% | -$886K | 0.04% | 442 |
|
|
2024
Q1 | $1.53M | Sell |
17,565
-2,250
| -11% | -$192K | 0.11% | 174 |
|
|
2023
Q4 | $1.63M | Sell |
19,815
-4,355
| -18% | -$332K | 0.14% | 142 |
|
|
2023
Q3 | $1.89M | Buy |
24,170
+8,167
| +51% | +$684K | 0.2% | 104 |
|
|
2023
Q2 | $1.41M | Sell |
16,003
-4,748
| -23% | -$409K | 0.15% | 140 |
|
|
2023
Q1 | $1.67M | Buy |
20,751
+3,458
| +20% | +$282K | 0.09% | 234 |
|
|
2022
Q4 | $1.34M | Sell |
17,293
-1,125
| -6% | -$91.2K | 0.08% | 250 |
|
|
2022
Q3 | $1.49M | Buy |
18,418
+4,864
| +36% | +$437K | 0.1% | 218 |
|
|
2022
Q2 | $1.22M | Sell |
13,554
-227
| -2% | -$23K | 0.08% | 256 |
|
|
2022
Q1 | $1.53M | Sell |
13,781
-282
| -2% | -$29.8K | 0.09% | 232 |
|
|
2021
Q4 | $1.45M | Buy |
14,063
+1,092
| +8% | +$126K | 0.09% | 225 |
|
|
2021
Q3 | $1.63M | Sell |
12,971
-293
| -2% | -$37.9K | 0.11% | 189 |
|
|
2021
Q2 | $1.65M | Buy |
13,264
+1,986
| +18% | +$249K | 0.12% | 190 |
|
|
2021
Q1 | $1.33M | Sell |
11,278
-2,295
| -17% | -$269K | 0.11% | 196 |
|
|
2020
Q4 | $1.59M | Buy |
13,573
+8,688
| +178% | +$956K | 0.14% | 159 |
|
|
2020
Q3 | $508K | Buy |
4,885
+63
| +1% | +$6.33K | 0.06% | 326 |
|
|
2020
Q2 | $442K | Buy |
4,822
+379
| +9% | +$36.3K | 0.06% | 328 |
|
|
2020
Q1 | $400K | Sell |
4,443
-972
| -18% | -$103K | 0.07% | 283 |
|
|
2019
Q4 | $615K | Buy |
5,415
+1,941
| +56% | +$213K | 0.08% | 278 |
|
|
2019
Q3 | $377K | Sell |
3,474
-37
| -1% | -$3.86K | 0.06% | 347 |
|
|
2019
Q2 | $342K | Sell |
3,511
-1,070
| -23% | -$97.7K | 0.07% | 309 |
|
|
2019
Q1 | $417K | Buy |
4,581
+1,196
| +35% | +$107K | 0.08% | 192 |
|
|
2018
Q4 | $308K | Buy |
3,385
+335
| +11% | +$31.3K | 0.08% | 276 |
|
|
2018
Q3 | $300K | Buy |
3,050
+486
| +19% | +$44.9K | 0.05% | 359 |
|
|
2018
Q2 | $220K | Buy |
+2,564
| New | +$214K | 0.06% | 306 |
|
|
2018
Q1 | – | Sell |
-7,837
| Closed | -$633K | – | 428 |
|
|
2017
Q4 | $633K | Buy |
+7,837
| New | +$628K | 0.14% | 169 |
|
Other funds holding MDT
VCM
VPM
Belpointe Asset Management's MDT Position: Q1 2026 in Review
Belpointe Asset Management reduced its Medtronic (MDT) stake by 31% in Q1 2026, selling an estimated $503K and leaving 11,461 shares worth $993K. The position accounts for 0.04% of the portfolio, ranked #455.
Belpointe Asset Management first reported a position in MDT in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.89M in Q3 2023. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Belpointe Asset Management held 11,461 shares of Medtronic worth $993K as of Q1 2026.
- Belpointe Asset Management sold 5,251 Medtronic shares in Q1 2026, an estimated $503K.
- Medtronic made up 0.04% of Belpointe Asset Management's portfolio in Q1 2026, its #455 holding.
- Belpointe Asset Management first reported a position in Medtronic in Q4 2017 and has held it in 33 quarters since.
- Belpointe Asset Management's Medtronic position peaked at $1.89M in Q3 2023.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.